Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 2/2020

01-04-2020 | Esophageal Varices | Case Report

Barrett’s adenocarcinoma with esophageal varices successfully treated by endoscopic submucosal dissection with direct varices coagulation

Authors: Chise Ueda, Tetsuya Yosizaki, Norio Katayama, Norihiro Okamoto, Hiroki Hashimura, Masanori Matsumoto, Megumi Takagi, Seitaro Ikeoka, Kenji Momose, Takaaki Eguchi, Hiroshi Yamashita, Akihiko Okada

Published in: Clinical Journal of Gastroenterology | Issue 2/2020

Login to get access

Abstract

A 67-year-old Japanese man with alcoholic cirrhosis underwent esophagogastroduodenoscopy (EGD), which revealed a 15-mm elevated lesion on the esophagogastric junction (EGJ). Endoscopic findings suggested that the lesion was an intramucosal cancer present on the esophageal varices. The location of the lesion at EGJ caused difficulties in endoscopic injection sclerotherapy and endoscopic variceal ligation for esophageal varices before esophageal endoscopic submucosal dissection (ESD). Direct varices coagulation treatment was therefore selected during ESD. Coagulation of bared varices with hemostatic forceps after mucosal incision enabled performing ESD without serious bleeding. 2 months afterwards, the patient underwent EGD, with no esophageal varices or carcinoma recurrence. Direct varices coagulation was effective for ESD of Barrett adenocarcinoma with esophageal varices.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tachibana M, Kotoh T, Kinugasa S, et al. Esophageal cancer with cirrhosis of the liver: results of esophagectomy in 18 consecutive patients. Ann Surg Oncol. 2000;7:758–63.CrossRef Tachibana M, Kotoh T, Kinugasa S, et al. Esophageal cancer with cirrhosis of the liver: results of esophagectomy in 18 consecutive patients. Ann Surg Oncol. 2000;7:758–63.CrossRef
2.
go back to reference Trivin F, Boucher E, Vauleon E, et al. Management of esophageal carcinoma associated with cirrhosis: a retrospective case-control analysis. J Oncol. 2009;2009:173421.CrossRef Trivin F, Boucher E, Vauleon E, et al. Management of esophageal carcinoma associated with cirrhosis: a retrospective case-control analysis. J Oncol. 2009;2009:173421.CrossRef
3.
go back to reference Kim JS, Kim BW, Shin IS. Efficacy and safety of endoscopic submucosal dissection for superficial squamous esophageal neoplasia: a meta-analysis. Dig Dis Sci. 2014;59:1862–9.CrossRef Kim JS, Kim BW, Shin IS. Efficacy and safety of endoscopic submucosal dissection for superficial squamous esophageal neoplasia: a meta-analysis. Dig Dis Sci. 2014;59:1862–9.CrossRef
4.
go back to reference Mitsuishi T, Goda K, Imazu H, et al. Superficial esophageal carcinomas on esophageal varices treated with endoscopic submucosal dissection after intravariceal endoscopic injection sclerotherapy. Gastroenterol Endosc. 2013;55:2189–96. Mitsuishi T, Goda K, Imazu H, et al. Superficial esophageal carcinomas on esophageal varices treated with endoscopic submucosal dissection after intravariceal endoscopic injection sclerotherapy. Gastroenterol Endosc. 2013;55:2189–96.
5.
go back to reference Tsou YK, Liu CY, Fu KI, et al. Endoscopic submucosal dissection of superficial esophageal neoplasms is feasible and not riskier for patients with liver cirrhosis. Dig Dis Sci. 2016;61:3565–71.CrossRef Tsou YK, Liu CY, Fu KI, et al. Endoscopic submucosal dissection of superficial esophageal neoplasms is feasible and not riskier for patients with liver cirrhosis. Dig Dis Sci. 2016;61:3565–71.CrossRef
6.
go back to reference Sawaguchi M, Jin M, Matsuhashi T, et al. The feasibility of endoscopic submucosal dissection for superficial esophageal cancer in patients with cirrhosis (with video). Gastrointest Endosc. 2014;79:681–5.CrossRef Sawaguchi M, Jin M, Matsuhashi T, et al. The feasibility of endoscopic submucosal dissection for superficial esophageal cancer in patients with cirrhosis (with video). Gastrointest Endosc. 2014;79:681–5.CrossRef
7.
go back to reference Poza Cordon J, Froilan Torres C, Burgos Garcia A, et al. Endoscopic management of esophageal varices. World J Gastrointest Endosc. 2012;4:312–22.CrossRef Poza Cordon J, Froilan Torres C, Burgos Garcia A, et al. Endoscopic management of esophageal varices. World J Gastrointest Endosc. 2012;4:312–22.CrossRef
8.
go back to reference Funakoshi K, Akiyama N, Kozakai I, et al. Successful endoscopic therapy of superficial esophageal cancer on varices in a patient with alcoholic liver cirrhosis. Dig Endosc. 2001;13:212–5.CrossRef Funakoshi K, Akiyama N, Kozakai I, et al. Successful endoscopic therapy of superficial esophageal cancer on varices in a patient with alcoholic liver cirrhosis. Dig Endosc. 2001;13:212–5.CrossRef
9.
go back to reference Wheeler JB, Reed CE. Epidemiology of esophageal cancer. Surg Clin N Am. 2012;92:1077–87.CrossRef Wheeler JB, Reed CE. Epidemiology of esophageal cancer. Surg Clin N Am. 2012;92:1077–87.CrossRef
10.
go back to reference Domper Arnal MJ, Ferrandez Arenas A, Lanas Arbeloa A. Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol WJG. 2015;21:7933–43.CrossRef Domper Arnal MJ, Ferrandez Arenas A, Lanas Arbeloa A. Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol WJG. 2015;21:7933–43.CrossRef
11.
go back to reference Amadi C, Gatenby P. Barrett's oesophagus: Current controversies. World J Gastroenterol WJG. 2017;23:5051–67.CrossRef Amadi C, Gatenby P. Barrett's oesophagus: Current controversies. World J Gastroenterol WJG. 2017;23:5051–67.CrossRef
12.
go back to reference Kawada K, Kawano T, Nakajima Y. Diagnosis of Barrett’s esophagus and Barrett’s esophageal cancer by endoscopy. Gastroenterol Endosc. 2017;59:70–80. Kawada K, Kawano T, Nakajima Y. Diagnosis of Barrett’s esophagus and Barrett’s esophageal cancer by endoscopy. Gastroenterol Endosc. 2017;59:70–80.
13.
go back to reference Westerterp M, Koppert LB, Bunkens CJ. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch. 2005;446:497–504.CrossRef Westerterp M, Koppert LB, Bunkens CJ. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch. 2005;446:497–504.CrossRef
14.
go back to reference Liu L, Hofstetter WL, Rashid A. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Am J Surg Pathol. 2005;29:1079–85.PubMed Liu L, Hofstetter WL, Rashid A. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Am J Surg Pathol. 2005;29:1079–85.PubMed
15.
go back to reference Oh DS, Hagen JA, Chandrasoma PT. Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus. J Am Coll Surg. 2006;203:152–61.CrossRef Oh DS, Hagen JA, Chandrasoma PT. Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus. J Am Coll Surg. 2006;203:152–61.CrossRef
16.
go back to reference Abraham SC, Krasinskas AM, Correa AM. Duplication of the muscularis mucosae in barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinoma. Am J Surg Pathol. 2007;31:1719–25.CrossRef Abraham SC, Krasinskas AM, Correa AM. Duplication of the muscularis mucosae in barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinoma. Am J Surg Pathol. 2007;31:1719–25.CrossRef
17.
go back to reference Ishihara R, Oyama T, Abe S. Risk of metastasis in adenocarcinoma of the esophagus: a multicenter retrospective study in a Japanese population. J Gastroenterol. 2017;52:800–8.CrossRef Ishihara R, Oyama T, Abe S. Risk of metastasis in adenocarcinoma of the esophagus: a multicenter retrospective study in a Japanese population. J Gastroenterol. 2017;52:800–8.CrossRef
18.
go back to reference Barbour AP, Jones M, Brown I. Risk stratification for early esophageal adenocarcinoma: analysis of lymphatic spread and prognostic factors. Ann Surg Oncol. 2010;17:2494–502.CrossRef Barbour AP, Jones M, Brown I. Risk stratification for early esophageal adenocarcinoma: analysis of lymphatic spread and prognostic factors. Ann Surg Oncol. 2010;17:2494–502.CrossRef
19.
go back to reference Bolton WD, Hofstetter WL, Francis AM. Impact of tumor length on long-term survival of pT1 esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2009;138:831–6.CrossRef Bolton WD, Hofstetter WL, Francis AM. Impact of tumor length on long-term survival of pT1 esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2009;138:831–6.CrossRef
20.
go back to reference Friedman LS. Surgery in the patient with liver disease. Trans Am Clin Climatol Assoc. 2010;121:192–204 (discussion 205).PubMedPubMedCentral Friedman LS. Surgery in the patient with liver disease. Trans Am Clin Climatol Assoc. 2010;121:192–204 (discussion 205).PubMedPubMedCentral
Metadata
Title
Barrett’s adenocarcinoma with esophageal varices successfully treated by endoscopic submucosal dissection with direct varices coagulation
Authors
Chise Ueda
Tetsuya Yosizaki
Norio Katayama
Norihiro Okamoto
Hiroki Hashimura
Masanori Matsumoto
Megumi Takagi
Seitaro Ikeoka
Kenji Momose
Takaaki Eguchi
Hiroshi Yamashita
Akihiko Okada
Publication date
01-04-2020
Publisher
Springer Singapore
Published in
Clinical Journal of Gastroenterology / Issue 2/2020
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-019-01048-9

Other articles of this Issue 2/2020

Clinical Journal of Gastroenterology 2/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.